All articles tagged with #dormant cells
Researchers at Penn Medicine have developed a test to detect and eliminate dormant breast cancer cells, potentially preventing cancer recurrence. The strategy involves using existing drugs to target these 'sleeper' cells before they become active, with ongoing clinical trials showing promising results, including reduced relapse rates and decreased patient anxiety.
Researchers have discovered that dormant breast cancer cells, which can cause relapse years after treatment, can be detected and eradicated using existing drugs, significantly reducing the risk of recurrence and offering new hope for survivors.
A new study in mice suggests that respiratory infections like COVID and flu can reactivate dormant breast cancer cells through immune responses involving IL-6, increasing the risk of metastasis and relapse. Protecting cancer survivors from infections and targeting IL-6 may help prevent cancer recurrence.
Scientists have found that respiratory illnesses like Covid and the flu can reactivate dormant cancer cells, leading to increased risk of metastasis, especially in cancer survivors. The inflammatory response, particularly the release of interleukin-6, appears to awaken these cells, which can then proliferate rapidly. Population studies support these findings, suggesting that respiratory infections may increase the risk of cancer recurrence and metastasis, highlighting the importance of vaccination and precautions for cancer patients.,
Research suggests that common respiratory viruses like COVID-19 and influenza may reactivate dormant breast cancer cells in the lungs, increasing the risk of metastasis and death among survivors, highlighting the importance of infection prevention and further studies on vaccination.